Jiasheng Bian
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025
CircIQGAP1-CARM1 axis promotes renal cell carcinoma progression through glycolytic reprogramming.
Journal: Cell death & disease
Published: October 15, 2025
Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma.
Journal: Research (Washington, D.C.)
Published: June 04, 2025
Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma.
Journal: Frontiers in pharmacology
Published: March 14, 2025
An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
Journal: PloS one
Published: June 17, 2022
LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
Journal: Cell death & disease
Published: February 11, 2021
Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
Journal: International urology and nephrology
Published: July 03, 2018
Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 09, 2015
Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China.
Journal: Journal of cancer research and clinical oncology
Published: April 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026